Aditxt, Inc. Files 8-K Report
Ticker: ADTX · Form: 8-K · Filed: Jul 10, 2025 · CIK: 1726711
Sentiment: neutral
Topics: filing, regulation-fd, exhibits
TL;DR
Aditxt filed an 8-K on July 8th, check it for updates.
AI Summary
On July 8, 2025, Aditxt, Inc. filed an 8-K report to disclose information under Regulation FD and to file financial statements and exhibits. The filing was made public on July 10, 2025. The company, formerly known as Aditx Therapeutics, Inc., is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing indicates Aditxt, Inc. is providing updated information to the SEC, which could include material developments or financial updates relevant to investors.
Risk Assessment
Risk Level: low — This is a routine filing for an 8-K, primarily disclosing information and exhibits without immediate, significant operational or financial news.
Key Players & Entities
- Aditxt, Inc. (company) — Registrant
- July 8, 2025 (date) — Date of earliest event reported
- July 10, 2025 (date) — Filing date
- Aditx Therapeutics, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- 2834 (sic_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the primary purpose of this 8-K filing by Aditxt, Inc.?
The primary purpose of this 8-K filing is to disclose information under Regulation FD and to file financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on July 8, 2025.
On what date was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on July 10, 2025.
What was Aditxt, Inc.'s former company name?
Aditxt, Inc.'s former company name was Aditx Therapeutics, Inc.
In which state is Aditxt, Inc. incorporated?
Aditxt, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 10, 2025 regarding Aditxt, Inc. (ADTX).